Insider filing · IBO
Heng Fai Ambrose Chan
Director
profile →
Heng Fai Ambrose Chan sold $1.1M of Impact Biomedical (IBO)
Executed Apr 2 2025, disclosed Apr 4 2025, 2 days later.
Value, as filed
$1.1M
1,687,344 sh across 6 lots
Executed
Apr 2 2025
the trade date, as filed
Disclosed
Apr 4 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HCHeng Fai Ambrose Chan (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in HWH International Inc. (HWH). Across 1 priced purchase filing, the average 21-session return was +15.4% from execution and +5.0% from disclosure (delay-adjusted; derived). The largest single filing was $500K of HWH (250,000 sh × $2.00, as filed), executed Jun 8.
The name
IBO
IBO
IBO · 6 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Heng Fai Ambrose Chan in IBO
IBOSALE
IMPACT BIOMEDICAL INC.
$176K351,555 sh × $0.50
Exec Apr 3 2025
Filed Apr 7 2025 · 5:30 PM ET IBOSALE IMPACT BIOMEDICAL INC. $2.9M
2,526,918 sh across 4 lots
Exec Mar 31 2025
Filed Apr 2 2025 · 5:30 PM ET